| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |